Contents

Current Pharmaceutical Design, Volume 20 - Number 24

Editorial

Editorial (Thematic Issue: The Lung and Winding Road: Twists and Turns on the Way to Personalized NSCLC Therapy)

, 20(24): 3861 - 3862

Michele Milella


DOI: 10.2174/13816128113196660766




Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"?

, 20(24): 3863 - 3874

Elena Galvani, Francesca Toffalorio, Godefridus J. Peters, Tommaso De Pas and Elisa Giovannetti


DOI: 10.2174/13816128113196660756




PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?

, 20(24): 3875 - 3882

Matteo Giaj Levra, Ken Andre Olaussen, Silvia Novello and Jean-Charles Soria


DOI: 10.2174/13816128113196660765




Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors

, 20(24): 3883 - 3893

Luciano Wannesson, Santiago Viteri, Carlota Costa, Niki Karachaliou, Miguel Angel Molina-Vila and Rafael Rosell


DOI: 10.2174/13816128113196660758




Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

, 20(24): 3894 - 3900

Paolo Maione, Antonio Rossi, Marianna Bareschino, Paola Claudia Sacco, Clorinda Schettino, Francesca Casaluce, Assunta Sgambato and Cesare Gridelli


DOI: 10.2174/13816128113196660764




Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...

, 20(24): 3901 - 3913

Massimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, Gennaro Daniele, Pasqualina Giordano, Raffaele Costanzo, Claudia Sandomenico, Agnese Montanino, Gaetano Rocco and Francesco Perrone


DOI: 10.2174/13816128113196660762




MET and ALK as Targets for the Treatment of NSCLC

, 20(24): 3914 - 3932

Capelletti M, Gelsomino F. and Tiseo M.


DOI: 10.2174/13816128113196660760




Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

, 20(24): 3933 - 3943

Sheila Piva, Monica Ganzinelli, Marina Chiara Garassino, Elisa Caiola, Gabriella Farina, Massimo Broggini and Mirko Marabese


DOI: 10.2174/13816128113196660761




Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC

, 20(24): 3944 - 3957

Ludovica Ciuffreda, Ursula Cesta Incani, Linda S. Steelman, Stephen L. Abrams, Italia Falcone, Anais Del Curatolo, William H. Chappell, Richard A. Franklin, Sabrina Vari, Francesco Cognetti, James A. McCubrey and Michele Milella


DOI: 10.2174/13816128113196660763




Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'

, 20(24): 3958 - 3972

Sara Pilotto, Maria Bonomi, Francesco Massari, Michele Milella, Ludovica Ciuffreda, Matteo Brunelli, Matteo Fassan, Marco Chilosi, Aldo Scarpa, Giampaolo Tortora and Emilio Bria


DOI: 10.2174/13816128113196660757




Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy

, 20(24): 3973 - 3981

Marcello Maugeri-Sacca, Monica Bartucci, Alfredo Pagliuca, Michele Patrizii, Michele Signore and Ruggero De Maria


DOI: 10.2174/13816128113196660759




MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

, 20(24): 3982 - 3990

D. Cortinovis, V. Monica, F Pietrantonio, G.L. Ceresoli, C.M. La Spina and L. Wannesson


DOI: 10.2174/13816128113196660755




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science